The Analgesic Effects of the Thoracic Paravertebral Block on Post-percutaneous Nephrolithotripsy: A Retrospective Study

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 5; p. e60272
• Main Authors: Js Medeiros, Heitor, Gee, Erica, Pak, Aimee, Hu, Vivian, Crawford, Lane, Razavi, Sarah, Anderson, T Anthony, Sabouri, A Sassan
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 14-05-2024; Cureus
• Subjects: Analgesics; Anesthesiology; Body mass index; Chronic pain; Demographics; Kidney stones; Missing data; Narcotics; Orthopedics; Patients; Regional anesthesia; Regression analysis; Sensitivity analysis; Ultrasonic imaging; Urology; pain; opioid-related disorders; percutaneous nephrolithotomy; nerve block; analgesia
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.60272

Percutaneous nephrolithotripsy (PCNL) is a minimally invasive procedure for treating large and complex kidney stones, often resulting in significant post-operative pain and increased opioid use. This study aims to compare pain scores between patients undergoing PCNL who did and did not receive a preoperative single-shot thoracic paravertebral block (PVB) at the post-anesthesia care unit (PACU) as the primary outcome. Secondary outcomes were patient-controlled analgesia (PCA) usage on post-operative day 1 (POD 1), total opioid consumption on PACU and POD 1, and post-operative nausea and vomiting (PONV).
A retrospective cohort study was conducted on the medical records of 341 patients who underwent PCNL from July 2014 to April 2016 in a single major academic center. PVB was administered at thoracic levels T7-9 using a volume of 20 cc of bupivacaine, ranging from 0.25% to 0.5%, to achieve the desired analgesic effect.
After excluding 34 patients, the study included 123 in the no block (NB) group and 149 in the regional anesthesia (RA) group. There were no differences in demographics, including age, sex, weight and height, BMI, and indication for PCNL. The results revealed that the RA group experienced a statistically significant reduction in PCA usage in both crude and adjusted models (adjusted logistic regression analysis: OR = 0.19, 95% CI = 0.05-0.60; p = 0.008). However, there were no significant changes in total opioid consumption, pain scores, or incidents of PONV.
The retrospective analysis did not reveal any discernible advantage in pain management associated with the use of PVB for post-PCNL analgesia, except for reducing the percentage of PCA narcotics used. Future investigations with larger sample sizes and meticulous control for surgical indications and complexity are imperative to accurately assess the efficacy of this block in the context of post-PCNL surgery.